Clinical Trials
21 trialsNCT06897488 2026-05-15
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05640999 2026-05-12
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT02633553 2026-04-24
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
Fudan University
Phase NA Recruiting
NCT06914440 2025-07-15
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Recruiting
NCT03721757 2025-02-25
NICO
The Clatterbridge Cancer Centre NHS Foundation Trust
Phase 2 Completed
NCT06814067 2025-02-07
Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
Fudan University
Phase 2 Not yet recruiting
NCT06272214 2024-07-16
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT06313073 2024-03-15
Neoadjuvant Radiotherapy for Breast Cancer
Changhai Hospital
Phase NA Unknown
NCT04989647 2023-09-07
CERVANTES
The Central and Eastern European Gynecologic Oncology Group
Phase 3 Recruiting
NCT05445648 2022-12-28
CBPTMI
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT00860652 2022-11-18
RAVES
Trans Tasman Radiation Oncology Group
Phase NA Active not recruiting
NCT05591456 2022-10-25
Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients
Zagazig University
Phase 3 Completed
NCT04740866 2021-02-09
Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer
Cairo University
Phase NA Unknown
NCT00003404 2019-01-22
Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT00822848 2018-09-07
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Phase 1 Completed
NCT03392103 2018-01-05
Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection
Zhongnan Hospital
Phase 2 Unknown
NCT01456156 2017-07-05
Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma
ChineseAMS
Phase NA Completed
NCT02891083 2016-09-07
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Phase 3 Unknown
NCT02668718 2016-02-02
Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer
Helsinki University Central Hospital
Phase 3 Unknown
NCT02570893 2015-10-07
A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT00128817 2013-01-23
Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers
Tata Memorial Hospital
Phase 3 Terminated